April 12, 2017 Columns by Laura Kolaczkowski RMS Patient Using Ocrevus in Trial: ‘I Feel Great’ Pamela Arterbridge is one of 70 people at Ohio State Universityās Multiple Sclerosis Center taking part in the open-label part of aĀ clinical trial for ocrelizumab, nowĀ best known asĀ Ocrevus.Ā She is a patient of Dr. Michael Racke, who is a pioneer in the field of B-cell treatmentsĀ for MS,…
April 11, 2017 Columns by Patricia Silva, PhD Importance of Elevators for Universal Housing You might think that the Fair Housing ActĀ required multifamily buildings to have elevators, but no, it doesn’t. A multifamily dwelling of four units that does not have an elevator is not required to have one. However, the ground floor units must be fully…
April 11, 2017 Columns by Teresa Wright-Johnson Chronic Illness and Dating: the Benefits of Transparency The dating process is the prerequisite to most serious relationships. We invest a significant amount of time to assess whether we are compatible with the person of interest. Dating should beĀ fun and we should look forward to future possibilities. For the past few days I’ve been thinking about dating…
April 11, 2017 Columns by Ed Tobias Need Help Paying for Your MS Drug? With last month’s approval of the multiple sclerosis drug Ocrevus, I’ve again heard the plea “But how can I afford it?” Ocrevus carries a price tag of about $65,000 a year. That’s not high compared to some other MS drugs, but it still can mean a higher…
April 10, 2017 Columns by Debi Wilson A Game of Spin the Bottle, Then Mono, EBV and MS A popular theory of what contributes to developing multiple sclerosis is a disease called mononucleosis (also known as glandular fever), which can be caused by Epstein-Barr virus (EBV). It is thought that the virus weakens our defenses in the blood-brain barrier, allowing white blood…
April 10, 2017 Columns by admin Pick of the Weekās News: Progression, Antibiotics, Ocrevus, Stem Cells, B-Cells Hereās my Pick of the Weekās News, as published by Multiple Sclerosis News Today. Canada, Worldās Multiple Sclerosis Capital, Launches 3-Way Collaboration to Research MS Progression Why some people develop primary progressive MS and others have the relapsing type, and why a many relapsing patients develop secondary…
April 7, 2017 Columns by Patricia Silva, PhD ABLE Act Improvements Reintroduced in Congress The ABLE Act improvement bills were reintroduced into CongressĀ this week and referred to committee on April 4.Ā The billsĀ died in committee in 2016 before an active campaign could garner enough attention in that election year. I urge all readers in the U.S. toĀ call yourĀ representatives and senators to encourage them to…
April 7, 2017 Columns by John Connor One Day in the Working Life of John Peter Connor These might be the days of the gig economy, but I’ve been doing one every Tuesday for 27 years. My particular white van (for US readers the delivery drivers of such are a British stereotype of the new Amazon order ā or lack of it) is a comedy vehicle…
April 7, 2017 Columns by Ed Tobias Ocrevus: Should I Switch? There was much fanfare when the multiple sclerosis drug Ocrevus (ocrelizumab) finally was approved by the U.S. Food and Drug Administration last week. Perhaps a little too much fanfare? For example, a story broadcast on the NBC Nightly News focused on a woman, apparently a participant in an…
April 6, 2017 Columns by Laura Kolaczkowski Ohio State Neurologist Shares Insight About MS B-Cell Therapy Ocrevus A prominent neurologist, who was involved in early research into B-cell therapy, tells Multiple Sclerosis News TodayĀ about his positive experience of using ocrelizumab, now branded Ocrevus, with patients. Michael Racke, MD, Department of Neurology at The Ohio State University WexnerĀ Medical Center took time to talk with me about…
April 6, 2017 Columns by Tamara Sellman The MS Alphabet: CAT, Clonus, Chemotherapy and More ‘C’ Words (Editor’s note: Tamara Sellman continues her occasional series on the MS alphabet with the first in a three-part series of terms starting with the letter “C.”) When it comes to multiple sclerosis, mastering an understanding of the disease means you need to mind your Ps and Qs, dot your…
April 6, 2017 Columns by admin ‘Fabulous’ Ocrevus Lights the Way to a Brighter, Hopeful Future, MS Nurse Says Ocrevus is a “fabulous” drug that does wonders for those who respond to it. Thatās the view of an MS nurse practitioner in Florida, with whom I spoke this week. Tricia Pagnotta works at the Multiple Sclerosis…
April 5, 2017 Columns by Judy Lynn If We Took a Holiday (from Our Meds) It Could Be So Nice! I was a teenager during the 1980s and cannot say the word āholidayā without Madonna’s song playing briefly in my head. For most holidays the perky music seems okay, but for discussion of a “drug holiday”Ā it feels a bit off. Sort of like, āYay! You have a chronic…
April 5, 2017 Columns by Mike Knight Going All In for Ocrevus ā Together āIs the MS drug news good for u?ā my friendās text asked. It was Wednesday morning, March 29. Genentech had just announcedĀ that Ocrevus, the āFirst and only approved disease-modifying therapy for primary progressive form of multiple sclerosis (PPMS) ā one of the most disabling forms of…
April 4, 2017 Columns by Teresa Wright-Johnson Ocrevus: FDA Approval Triggers Hope, Optimism ā and Concern ā Among MS Patients The past few days have been remarkable in the multiple sclerosis (MS) community, with the U.S. Food and Drug Administration (FDA) approving Ocrevus to treat relapsing MS (RRMS) and primary progressive MS (PPMS) in the United States. Ocrevus ā adminstered intravenously every six months ā is the first drug…
April 4, 2017 Columns by Ed Tobias Ampyra: A Generic for the MS ‘Walking Drug’ Wins a Round in Court Ampyra is marketed as the only multiple sclerosis (MS) drug that is designed to increase an MS patient’s walking speed. Clinical studies show that patients who use the drug walk as much as 20 percent faster. Ampyra improved my speed, several years ago, when I was on…
April 3, 2017 Columns by Debi Wilson Is Ocrevus Right for Me? So Close, Yet So Far History has been made because of a major breakthrough for multiple sclerosis sufferers everywhere. Ocrevus (ocrelizumab),Ā by Genentech, has been finally approved by the U.S. Food and Drug Administration. It is the first drug treatment that includes my type of MS, primary progressive. This is what I’ve…
April 3, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Ocrevus and Its Approval, Reactions, Development, Dispensing, Other Countries Today, myĀ Pick of the Week’s News is devoted to various news stories,Ā all published by Multiple Sclerosis News Today,Ā about FDA approval of Genentech’s OcrevusĀ as an MS treatment. FDA Approves Ocrevus as 1st MS Treatment for Both Relapsing and Primary Progressive Forms Last weekās approval of Ocrevus (ocrelizumab) by…
March 31, 2017 Columns by Jamie Hughes A Word, If You Please Thirteen years ago, a neurologist sat on the edge of my hospital bed and told me, āYou have MS. Itās not the end of the world. Thereās more on the internet than I could ever tell you about, so I suggest you do some research. Good night.ā Since…
March 31, 2017 Columns by John Connor Request for Tennis Lessons Leads to Academy Teaching Many Disabled In the summer of 2012 David Bowie’s song “Heroes” became the anthem of the London Olympics despite Bowie turning down an invitation from British director Danny Boyle to be part of the opening ceremony. Gracious as ever, Bowie agreed to a meeting. Boyle had a lot to thank him for.Ā Bowie…
March 31, 2017 Columns by Ed Tobias Scooters: Don’t Let Pride Block Your Path to Independence To scoot or not to scoot? Is is better to drag your legs around for as long as you can, or to give in and get yourself a set of electric wheels? That decision prompted the following vent on a multiple sclerosis Facebook group recently: “I’m just…
March 30, 2017 Columns by Laura Kolaczkowski Making Some Valid Points About Acupuncture and MS Have you ever used acupuncture?Ā I have a number of times and would doĀ so more often if it were a medical service covered by my insurance. Unfortunately, for now, most complementary treatments we have available to help with the symptoms of multiple sclerosis are not covered by commercial insurance. In…
March 30, 2017 Columns by Tamara Sellman United Airlines Dress Code is Wrong, Especially for MS Patients It appears my favorite way to fly ā wearing leggings or yoga pants ā isn’t sanctioned by United Airlines. Fortunately, I’m not one of their employees, and I am not related to one who might be able to share free travel passes with me. HowĀ sad. Normally that would be a…
March 30, 2017 Columns by admin Dan Says Treasure Your Caregiving Hero Caregivers are in the spotlight during MS Awareness Month and, as it draws to a close, one man with multiple sclerosis is calling for everyone with the disease to recognize them. Dan Melfi, who lives in the…
March 29, 2017 Columns by Judy Lynn The Anniversary Effect: How Do You Remember Your Diagnosis Date? Editor’s note: Marking the second MS diagnosis anniversary of our columnists in oneĀ week, Judy Lynn writes about the “Anniversary Effect.” This week marks the 14th anniversary of my MS diagnosis. That day, March 27, 2003, is etched clearly in my mind.Ā Ask me about anything else I was doing…
March 29, 2017 Columns by Cathy Chester Integrative Medicine for MS: an Interview with Dr. Bowling When you live with multiple sclerosis you search for ways to manage your disease. You turn to doctors who inevitably prescribe one of the many FDA-approved medications, but sometimes thatās not enough. To complete the picture of seeking better health, you need to also look outside…
March 28, 2017 Columns by Patricia Silva, PhD Dedicated Handicapped Parking is About Availability, Not Cost Being disabled by MS does not have many advantages. One ā free city street parking in California ā is likelyĀ to end soon.Ā In the rush to garner parking revenue, though, the lack of concurrent discussion about providing dedicated handicapped parking (DHP) is troubling. The widespread abuse…
March 28, 2017 Columns by Teresa Wright-Johnson The Detriment of Unsolicited Advice Regarding MS and Chronic Illness I am sure many of us have had instances where someone āofferedā their advice on what is the best way to manage our illnesses. They are not medical professionals and many of them don’t suffer from the disease themselves. They present their beliefs as scientific dogma, often referring to…
March 28, 2017 Columns by Ed Tobias My MS Is Getting to Be a Pain, Literally For most of the 36 years since I was diagnosed with multiple sclerosis I’ve not been bothered by pain. Just lucky, I guess. Until last month. Suddenly, I’ve developed pain in both hips and I don’t know why. The pain is most intense when I first put my feet on…
March 27, 2017 Columns by Tamara Sellman Why It’s Important to Observe Your Diagnosis Anniversary On March 27, 2013, my primary care physician called me about MRI results from the day before. He and the radiologist concurred; they had foundĀ evidence of brain lesions consistent withĀ multiple sclerosis. Following protocol, heĀ sentĀ me to the best specialist in SeattleĀ to confirm diagnosis. His was aĀ preliminary diagnosis. In the…